Aims of the Committee

Provides financial support to further the IAC’s mission of education, training and research.

Responsibilities

  • Explore creative and innovative ways to launch fundraising campaigns to bring in new sources of financial support.
  • Set up 3-yearly fundraising goals (with yearly sub-goals) and present them to the board.
  • Establish 3-yearly “major theme” to enhance awareness among membership.
  • Identify “key donors” and solicit industry support and send yearly reminders along with a note of thanks.
  • Coordinate and liaise with other related committees to better promote, advertise and increase foundation’s visibility (communication committee and the committee on continuing education and quality assurance).
  • Closely work with the “Budget and Finance Committee” for all financial and investment matters.

Chair

Dr. Martha Pitman, MIAC (USA)

Dr. Pitman is Professor of Pathology at Harvard Medical School and practising pathologist in Cytopathology and gastrointestinal surgical pathology at Massachusetts General Hospital. She has been Associate Editor of Cancer Cytopathology and The Journal of the American Society of Cytopathology and is currently active on the editorial boards of several journals. She is the lead author of the PSC Pancreaticobiliary Terminology System for reporting pancreaticobiliary cytology as well as the new WHO Reporting System for Pancreaticobiliary Cytology. She is also on the Standing Committee (one of 5 series editors) for all WHO Reporting Systems.


Members

Dr. Hatim Al-Maghraby

Dr. Hatim al-Maghraby (Saudi Arabia)

Dr. Hatim Qasim Al-Maghrabi, MD, FRCPC, IFCAP
Chairman, Department of Pathology and Laboratory Medicine.King Faisal Specialist Hospital & Research Centre – Madinah, Saudi Arabia
Dr. Hatim Qasim Al-Maghrabi graduated from King Abdulaziz University Medical School, Jeddah, and completed his anatomical pathology residency at the University of Ottawa, obtaining the Fellowship of the Royal College of Physicians and Surgeons of Canada in 2008. He pursued further clinical fellowship subspecialty training in Cytopathology and Renal & Liver pathology at the University of Toronto.
From 2010 to 2023, Dr. Al-Maghrabi served as Consultant Pathologist at King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, where he was also Residency Training Program Director (2010–2018) and Assistant Professor at King Saud bin Abdulaziz University for Health Sciences.
Currently Chairman of the Department of Pathology and Laboratory Medicine at King Faisal Specialist Hospital & Research Centre – Madinah, Dr. Al-Maghrabi’s expertise includes cytopathology, renal and liver pathology, and digital pathology. He is a Fellow of the College of American Pathologists and a Medical Member of the IAC, actively contributing to education and quality improvement initiatives nationally and internationally.

Dr Claire Bourgain, MIAC (Belgium)

Dr. Bourgain is Head of the Department of Pathology at Imelda Hospital, Bonheiden, Leuven, Belgium.


Dr. Ashish Chandra, MIAC (united Kingdom)

Dr. Ashish Chandra is the lead uropathologist and cytopathologist at Guy’s & St. Thomas’ Hospitals, London where he has been based since 2001. He is a member of the Cytopathology Specialist Advisory Committee at RCPath, is an active member of the British Association of Cytopathology (BAC) and Deputy editor of the journal, Cytopathology.


Amber Donnelly, PhD

Amber Donnelly (U.S.A)

Dr. Donnelly is the Associate Dean of Academic and Student Affairs and Professor in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC). Her approach to cytology education and the creation of satellite sites across the U.S. led to being recognized as a leader in distance education and innovative technology.  Dr. Donnelly served as the Chair for the Cytology Programs Review Committee (CPRC) which oversees the accreditation of Cytology programs in the U.S.  She has also served as chair or member of national committees, including the executive boards for the American Society of Cytopathology (ASC) and the Commission on Accreditation of Allied Health Education Programs (CAAHEP).  Because of her expertise and passion for cytology education, she has been invited to speak on many occasions.  Dr. Donnelly has published in scientific journals and has been granted national awards for education and educational research.


Andrew Field, MB BS (Hons), FRCPA, FIAC (Australia)

Dr. Field is head of the Department of Anatomical Pathology at St Vincent’s Hospital, Sydney, and Associate Professor at the University of New South Wales and Notre Dame University Medical Schools. He is currently the President of the International Academy of Cytology and a foundation member of African Strategies for Advancing Pathology, an organization that aims to advocate for and coordinate improvements in pathology services throughout Africa.


Dr. Angel Fomperoza Torres, FIAC (México)

Dr Angel Fomperoza Torres is a Professor of Pathology and Director of Cytopathology at Veracruzana University School of Medicine in Veracruz, Mexico.Director of Anatomical Pathology and Cytopathology department at Petroleos Mexicanos Minatitlan Regional Hospital, in Veracruz México. Past President of the Mexican Academy of Cytopathology (AMCP), Fellowship of the International Academy of Cytology (FIAC), President of the XXXI Congress of the Latin American Society of Cytology, and Supervisor of the screening program of Cervical Cancer in México.


Dr. Pamela Michlow, MIAC (South Africa)

Dr Pamela Michelow currently has a joint post at the University of the Witwatersrand and the National Health Laboratory Service, South Africa. She has continuing interests in visual literacy, the roles of exfoliative and aspiration biopsy cytology in under-resourced communities and in quality standards in cytopathology.


Dr. Mauro Saieg, FIAC (Canada)

Dr. Saieg holds a position as Associate Professor, Department of Pathology, Jewish General Hospital, McGill University. He also serves currently as Associate Editor of Cytopathology, the British Association for Cytopathology Journal. He has served as President of the Brazilian Society of Cytopathology, as Scientific Director of the Latin American Society of Cytopathology and as member of several editorial boards, such as Cancer Cytopathology, Diagnostic Cytopathology and the Journal of the American Society of Cytopathology.


Dr. Robert Y. Osamura, FIAC (Japan)

Dr. Robert Y. Osamura has been an active member and Fellow (FIAC) for many years. He served as President of IAC from 2016 to 2019. During his Presidency, he emphasized the importance of “on-site” education of cytology and represented IAC leadership in seven international tutorials in various countries across the globe. These tutorials were very well received within the IAC and in the world of cytopathology in general. 


Dr. Momin T. Siddiqui, FIAC (USA)

Dr. Momin T. Siddiqui is a Professor of Pathology and Laboratory Medicine at Weill-Cornell in New York. He currently, also serves as the Medical Director of the Papanicolaou Cytopathology Laboratory at Cornell and also directing the cytopathology fellowship program. Dr. Siddiqui is also a Past-President of the American Society of Cytopathology. He has also served on numerous national and international pathology organizational executive boards and committees in the last two decades. 


Dr. Sule Canberk (Portugal)

Dr. Sule Canberk, MD, PhD, MIAC, is an endocrine pathologist and cytopathologist, with a particular focus on oncocytic tumors of the thyroid. She earned her PhD in Molecular Pathology and Genetics at the University of Porto, where her research explored the molecular basis of oncocytic thyroid tumors, highlighting the tumorigenesis mechanism. Currently, she serves as an Assistant Professor at the Pathology Department of Medical Faculty of Porto Universityand a researcher atRISE Health, establishing her research group, PathOmics, which focuses on integratingpathology, molecular diagnostics, and bioinformatics to enhance precision medicine approaches in endocrine neoplasms.

With over 80 peer-reviewed publications, 6 book chapters and leadership in multi-institutional research projects, Dr. Canberk has contributing to a better understanding of thyroid oncocytic neoplasms. She is an active member of international research networks and a frequent speaker at major pathology congresses, bringing a translational perspective to endocrine tumor diagnostics and biomarker discovery.


Ex-Officio Members

Dr. Syed, Z. Ali

dr. Syed Z. Ali, MD, FRCPath, FIAC (USA)

Prof. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital/Cornell University in New York with fellowships in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital in Baltimore.

Known globally as an innovative educator, Prof. Ali has well over 375 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.

Prof. Ali has published extensively with over 335 peer-reviewed articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” (now in its 3rd edition) has been translated in 8 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and a past-President of the American Society of Cytopathology (ASC). Presently, he serves as the President of the International Academy of Cytology (IAC) and Chair of the International Board of Cytopathology of the IAC. He is a fellow of both the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, “President’s Award” in 2012, “Excellence in Education Award” in 2015, the IAC’s “Maurice Goldblatt Award” in 2019, Papanicolaou Society of Cytopathology’s “LC Tao Educator of the Year Award” in 2022 and the ASC’s “Papanicolaou Award” in 2023.


Massimo Bongiovanni, MD, FIAC (Switzerland)

Dr. Bongiovanni is head of Cytopathology at SYNLAB Pathology in Lausanne, Switzerland. He is member of the Pathology Expert Group, at SYNLAB International, Member (MIAC) and then Fellow (FIAC) of the International Academy of Cytology since 2016. He is the author of more than 200 scientific articles and 15 book chapters. He was Vice President of the Swiss Cytology Society (2015-2021) and a member of the Endocrine Tumor Group of the European Organisation for Research and Treatment of Cancer (EORTC). He is associate editor of the journal Acta Cytologica and participates in the editorial board of the journal Diagnostic Cytopathology. He is currently co-chair of the scientific committee of the European Federation of Cytology Societies (EFCS).